Belluscura PLC Applications Announcement (7986L)
17 May 2022 - 9:00PM
UK Regulatory
TIDMBELL
RNS Number : 7986L
Belluscura PLC
17 May 2022
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES
OF ARTICLE 7 OF THE UK VERSION OF THE MARKET ABUSE REGULATION (EU)
NO.596/2014, WHICH FORMS PART OF UK LAW BY VIRTUE OF THE EUROPEAN
UNION (WITHDRAWAL) ACT 2018 ("UK MAR").
Belluscura plc
("Belluscura", the "Company" or the "Group")
Allotment of shares
Belluscura plc (AIM: BELL), a leading medical device developer
focused on lightweight and portable oxygen enrichment technology,
announced on 13 May 2022 the result of a Placing to raise
approximately GBP6.0 million by way of the issue of 7,058,824
Placing Shares at an issue price of 85 pence per ordinary
share.
The Placing Shares will be issued credited as fully paid and
will rank pari passu with the Existing Ordinary Shares and
represent approximately 6.2 per cent. of the Existing Ordinary
Shares.
The Company has allotted, subject to First Admission (as defined
below), 1,137,630 EIS/VCT Placing Shares and, subject to Second
Admission (as defined below), 5,921,194 General Placing Shares.
Admission and dealings
Application has been made for 1,137,630 EIS/VCT Placing Shares,
issued pursuant to the Placing, to be admitted to trading on AIM
which is expected to occur at 8.00 a.m. on 18 May 2022 ("First
Admission").
Application has also been made for 5,921,194 General Placing
Shares, also issued pursuant to the Placing, to be admitted to
trading on AIM which is expected to occur at 8.00 a.m. on 19 May
2022 ("Second Admission").
Total voting rights
Following First Admission, the issued share capital of the
Company will comprise 115,306,407 Ordinary Shares, none of which
are held in treasury. Therefore, following First Admission, the
total number of Ordinary Shares with voting rights in the Company
will be 115,306,407 Ordinary Shares, which may be used by
shareholders as the denominator for the calculations by which they
will determine if they are required to notify their interest in, or
a change to their interest in, the Company under the FCA's
Disclosure Guidance and Transparency Rules.
Following Second Admission, the issued share capital of the
Company will comprise 121,227,601 Ordinary Shares, none of which
are held in treasury. Therefore, following Second Admission, the
Enlarged Share Capital of the Company and total number of Ordinary
Shares with voting rights in the Company will be 121,227,601
Ordinary Shares, which may be used by shareholders as the
denominator for the calculations by which they will determine if
they are required to notify their interest in, or a change to their
interest in, the Company under the FCA's Disclosure Guidance and
Transparency Rules.
Capitalised terms used in this announcement have the meanings
given to them in the Launch Announcement of 12 May 2022, unless the
context provides otherwise.
For further information please contact:
Belluscura plc www.belluscura.com
Robert Rauker, Chief Executive Officer via Walbrook PR
Anthony Dyer, Chief Financial Officer
SPARK Advisory Partners Limited (NOMAD) Tel: +44 (0)20 3368 3550
Neil Baldwin
Dowgate Capital Limited (Sole Broker and Sole Bookrunner) Tel: +44 (0)20 3903 7715
James Serjeant / Nicholas Chambers
Walbrook PR Ltd (Media & Investor Relations) Tel: +44 (0)20 7933 8780 or belluscura@walbrookpr.com
Paul McManus / Sam Allen Mob: +44 (0)7980 541 893 / +44 (0)7502 558 258
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
ALSARMMTMTIBBAT
(END) Dow Jones Newswires
May 17, 2022 07:00 ET (11:00 GMT)
Belluscura (LSE:BELL)
Historical Stock Chart
From Apr 2024 to May 2024
Belluscura (LSE:BELL)
Historical Stock Chart
From May 2023 to May 2024